SINGAPORE, March 24, 2026 /PRNewswire/ -- Global social entertainment platform WePlay operated by WEJOY PTE. LTD., recently received strong recognition from App Store Today for its Lunar New Year campaign launched across Southeast Asia in February. The themed event was not only selected for the App Store Toda...
SINGAPORE, March 24, 2026 /PRNewswire/ -- Global social entertainment platform WePlay operated by WEJOY PTE. LTD., recently received strong recognition from App Store Today for its Lunar New Year campaign launched across Southeast Asia in February. The themed event was not only selected for the App Store Toda...
BEIJING, March 23, 2026 /PRNewswire/ -- A report from People's Daily: Photo shows the Xiong'an Urban Computing Center. (People's Daily/Lei Sheng) As night falls, a deep-blue "eye" gazes into the distance. Located in the western part of the Rongdong District of Xiong'an New Area, north China's ...
BEIJING, March 23, 2026 /PRNewswire/ -- A report from People's Daily: Photo shows the Xiong'an Urban Computing Center. (People's Daily/Lei Sheng) As night falls, a deep-blue "eye" gazes into the distance. Located in the western part of the Rongdong District of Xiong'an New Area, north China's ...
Robust Revenue & Profit Growth Highlights Resilience of a Leading Chinese Catering Enterprise HANGZHOU, China, March 24, 2026 /PRNewswire/ -- In 2025, amid a challenging operating environment, Green Tea Group achieved rapid growth by leveraging its over-20-year brand heritage. The Group recorded revenue of RMB4,76...
Robust Revenue & Profit Growth Highlights Resilience of a Leading Chinese Catering Enterprise HANGZHOU, China, March 24, 2026 /PRNewswire/ -- In 2025, amid a challenging operating environment, Green Tea Group achieved rapid growth by leveraging its over-20-year brand heritage. The Group recorded revenue of RMB4,76...
CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS SYDNEY, March 24, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing of the first participant in its Phase 1b KOANEWA trial eva...
CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS SYDNEY, March 24, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing of the first participant in its Phase 1b KOANEWA trial eva...
MANILLA, Philippines, March 24, 2026 /PRNewswire/ -- Great Place To Work® ASEAN & ANZ has announced the annual Best Workplaces in The Philippines 2026. This year's recognition is built on insights from 241,285 employees, representing the voices of 450,074 workers all across The ...
MANILLA, Philippines, March 24, 2026 /PRNewswire/ -- Great Place To Work® ASEAN & ANZ has announced the annual Best Workplaces in The Philippines 2026. This year's recognition is built on insights from 241,285 employees, representing the voices of 450,074 workers all across The ...